Meta-analysis of sotagliflozin, a dual sodium-glucose-cotransporter 1/2 inhibitor, for heart failure in type 2 diabetes
| dc.contributor.author | Bantounou, Maria Anna | |
| dc.contributor.author | Sardellis, Panagiotis | |
| dc.contributor.author | Plascevic, Josip | |
| dc.contributor.author | Awaes-Mahmood, Ribeya | |
| dc.contributor.author | Kaczmarek, Justyna | |
| dc.contributor.author | Black Boada, Daniel | |
| dc.contributor.author | Thuemmler, Rosa | |
| dc.contributor.author | Philip, Sam | |
| dc.contributor.institution | University of Aberdeen.Other Applied Health Sciences | en |
| dc.contributor.institution | University of Aberdeen.Aberdeen Centre for Health Data Science | en |
| dc.date.accessioned | 2025-03-17T10:40:01Z | |
| dc.date.available | 2025-03-17T10:40:01Z | |
| dc.date.issued | 2025-04 | |
| dc.description.status | Peer reviewed | en |
| dc.format.extent | 12 | |
| dc.format.extent | 1359544 | |
| dc.identifier | 297963235 | |
| dc.identifier | c622b9be-26aa-48fa-ba1d-adc466750fe9 | |
| dc.identifier | 85203444964 | |
| dc.identifier.citation | Bantounou, M A, Sardellis, P, Plascevic, J, Awaes-Mahmood, R, Kaczmarek, J, Black Boada, D, Thuemmler, R & Philip, S 2025, 'Meta-analysis of sotagliflozin, a dual sodium-glucose-cotransporter 1/2 inhibitor, for heart failure in type 2 diabetes', ESC Heart Failure, vol. 12, no. 2, pp. 968-979. https://doi.org/10.1002/ehf2.15036 | en |
| dc.identifier.doi | 10.1002/ehf2.15036 | |
| dc.identifier.iss | 2 | en |
| dc.identifier.issn | 2055-5822 | |
| dc.identifier.other | ORCID: /0000-0001-6164-211X/work/171446483 | |
| dc.identifier.uri | https://hdl.handle.net/2164/25149 | |
| dc.identifier.url | http://www.scopus.com/inward/record.url?scp=85203444964&partnerID=8YFLogxK | en |
| dc.identifier.vol | 12 | en |
| dc.language.iso | eng | |
| dc.relation.ispartof | ESC Heart Failure | en |
| dc.subject | SDG 3 - Good Health and Well-being | en |
| dc.subject | heart failure | en |
| dc.subject | meta-analysis | en |
| dc.subject | sodium-glucose co-transporter 1 (SGLT1) | en |
| dc.subject | sodium-glucose co-transporter 2 (SGLT2) | en |
| dc.subject | sotagliflozin | en |
| dc.subject | type 2 diabetes mellitus | en |
| dc.subject | R Medicine | en |
| dc.subject | Cardiology and Cardiovascular Medicine | en |
| dc.subject | Supplementary Data | en |
| dc.subject | DAS | en |
| dc.subject | Supplementary Information | en |
| dc.subject.lcc | R | en |
| dc.title | Meta-analysis of sotagliflozin, a dual sodium-glucose-cotransporter 1/2 inhibitor, for heart failure in type 2 diabetes | en |
| dc.type | Journal item | en |
Files
Original bundle
1 - 1 of 1
- Name:
- Bantounou_etal_ESCHF_Meta-Analysis_of_Sotaglizflozin_VOR.pdf
- Size:
- 1.3 MB
- Format:
- Adobe Portable Document Format
